Trials / Completed
CompletedNCT01850823
Clinical Equivalence Study of Mometasone Nasal Spray
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 880 (actual)
- Sponsor
- Actavis Inc. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Watson Laboratories, Inc) with NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | |
| DRUG | Mometasone Nasal Spray | |
| DRUG | Mometasone nasal spray |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2013-05-10
- Last updated
- 2020-08-19
- Results posted
- 2020-08-19
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01850823. Inclusion in this directory is not an endorsement.